21st Century healthcare is facing a crisis due to rising life expectancy and an increase in the incidence of many age-related diseases that currently have no cure. Illnesses such as Alzheimer’s, Parkinson’s, diabetes, heart failure and blindness place enormous financial burden on healthcare providers and significantly reduce quality of life for sufferers. Regenerative medicine is an emerging field that aims to utilise the power of stem cells and tissue engineering to overcome these diseases.
However, translating the discovery science into manufacturable products has so far been challenging and so multi-disciplinary engineers are urgently needed to bring new engineering solutions to the manufacture of these complex medical products. UCL engineers will learn about these emerging medicines and then focus their engineering skills to appraise existing devices, tools and technologies for processing and analytics that are used during manufacture.
Manufacturing for living cell products, along with advanced biomaterials processing for tissue engineering and drug delivery, will be assessed in the first two modules. In the final module, students will undertake a design-based project to create a new manufacturing process for a typical regenerative medicine product, with feedback from potential future employers including industrialists and the Cell Therapy Catapult. The outcome for the student will be a strong grounding in the application of manufacturing tools for new medicines that will define 21st Century healthcare.
Information for Current Students
For current module breakdown and syllabus, please have a look at the Minor page on the IEP Central Moodle (current students ONLY, login required).
Dr Qasim Rafiq
Dept Biochemical Engineering
Choose your IEP Minor
Please select your preferred Minor via the IEP Minors Moodle Poll